docetaxel anhydrous has been researched along with gastrins in 2 studies
| Studies (docetaxel anhydrous) | Trials (docetaxel anhydrous) | Recent Studies (post-2010) (docetaxel anhydrous) | Studies (gastrins) | Trials (gastrins) | Recent Studies (post-2010) (gastrins) |
|---|---|---|---|---|---|
| 12,110 | 3,216 | 6,920 | 12,748 | 659 | 786 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clarke, PA; Evans, SA; Gilliam, AD; Grabowska, AM; Harris, JC; McKenzie, AJ; McWilliams, DF; Watson, SA | 1 |
| Adams, DJ; Kulhari, H; Kuncha, M; Pooja, D; Singh, MK; Sistla, R | 1 |
2 other study(ies) available for docetaxel anhydrous and gastrins
| Article | Year |
|---|---|
The biological and therapeutic importance of gastrin gene expression in pancreatic adenocarcinomas.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Deoxycytidine; DNA, Antisense; Docetaxel; Gastrins; Gemcitabine; Gene Expression; Genetic Therapy; Humans; Male; Mice; Mice, Nude; Pancreatic Neoplasms; Phosphorylation; Protein Precursors; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Taxoids; Transfection | 2004 |
Bombesin-conjugated nanoparticles improve the cytotoxic efficacy of docetaxel against gastrin-releasing but androgen-independent prostate cancer.
Topics: Androgens; Animals; Antineoplastic Agents; Bombesin; Cell Line, Tumor; Docetaxel; Drug Delivery Systems; Gastrins; Humans; Male; Mice, Inbred BALB C; Nanoparticles; Prostate; Prostatic Neoplasms; Taxoids | 2015 |